Position in CRMD
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$787,366
-$465,974 QoQ
Shares Held
115,960
+7.6% QoQ
Ownership
0.148%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 73%
Shared 0%
None 27%
Common Shares in CRMD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026JPMORGAN CHASE & CO holds $16,579,226,864 across 407 Biotechnology names. CRMD ranks #176 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
24,150,499 | $3,949,089,591 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,311,806 | $3,331,473,778 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
7,033,156 | $3,140,585,469 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
6,323,752 | $2,092,339,815 | |
| 5 | NUVL |
Nuvalent, Inc.
|
3,088,349 | $316,401,351 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,204,353 | $227,682,931 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
2,363,567 | $177,480,242 | |
| 8 | TERN |
Terns Pharmaceuticals, Inc.
|
2,869,728 | $151,292,056 |
All Filings in CRMD
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $787,366 | 115,960 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $1,253,340 | 107,768 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $1,130,759 | 97,228 | Shares | Defined | 2025-11-26 | |
| 2025-06-30 | $432,960 | 35,143 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $223,218 | 36,237 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $2,213,064 | 273,218 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $1,568,392 | 194,108 | Shares | Defined | 2024-12-26 | |
| 2024-06-30 | $106,997 | 24,711 | Shares | Defined | 2024-12-26 | |
| 2024-03-31 | $94,313 | 22,244 | Shares | Defined | 2024-12-26 | |
| 2023-12-31 | $141,845 | 37,725 | Shares | Defined | 2024-12-26 | |
| 2023-09-30 | $127,904 | 34,569 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $232,951 | 58,678 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $822 | 195 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $61,079 | 21,583 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $317,068 | 78,873 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $221,621 | 40,442 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $175,056 | 38,474 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $125,940 | 27,084 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $346,038 | 50,443 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $582,874 | 58,346 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $636,891 | 85,719 | Shares | Defined | 2021-02-19 | |
| 2020-09-30 | $173,796 | 28,822 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $87,972 | 13,964 | Shares | Defined | 2020-08-11 | |
| 2020-03-31 | $29,312 | 8,165 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||